Dark Forest Capital Management’s Vir Biotechnology VIR Stock Holding History

Dark Forest Capital Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-143,068	Closed	-$817K	–	1374
2025 Q3	$817K	Buy	+143,068	New	+$732K	0.03%	804
2023 Q3	–	Sell	-29,877	Closed	-$733K	–	1329
2023 Q2	$733K	Buy	29,877 +20,720	+226%	+$520K	0.07%	447
2023 Q1	$213K	Buy	+9,157	New	+$234K	0.05%	356
2022 Q3	–	Sell	-69	Closed	-$2K	–	1450
2022 Q2	$2K	Buy	+69	New	+$1.61K	﹤0.01%	746
2022 Q1	–	Sell	-48	Closed	-$2K	–	1790
2021 Q4	$2K	Sell	48 -926	-95%	-$36.3K	﹤0.01%	1309
2021 Q3	$42K	Buy	974 +265	+37%	+$11.5K	0.01%	606
2021 Q2	$34K	Buy	+709	New	+$32.2K	0.01%	499

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Dark Forest Capital Management's VIR Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 143,068 shares — an estimated $817K sold.

Dark Forest Capital Management first reported a position in VIR in Q2 2021 and held it in 7 quarters. The position peaked at $817K in Q3 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

Dark Forest Capital Management reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 143,068 Vir Biotechnology shares in Q4 2025, an estimated $817K.
Dark Forest Capital Management first reported a position in Vir Biotechnology in Q2 2021 and held it in 7 quarters.
Dark Forest Capital Management's Vir Biotechnology position peaked at $817K in Q3 2025.
218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.